Document Detail


The effect of parity and gravidity on the outcome of medical termination of pregnancy.
MedLine Citation:
PMID:  21090516     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Previous pregnancies may influence the success of medical termination of pregnancy.
OBJECTIVES: To determine the effect of parity and gravidity on the successful termination of pregnancy using mifepristone and misoprostol.
METHODS: The medical files of all patients attending a department of obstetrics and gynecology during the years 2006 and 2007 for the purpose of medical termination of pregnancy at < or = 49 days of gestation were analyze retrospectively. The medical history, previous pregnancies and deliveries were recorded. Mifepristone was administered orally followed by 400 mg of misoprostol 48 hours later. A second dose of misoprostol was offered 2 weeks later if uterine content thickness was more than 15 mm. Then, after 24 hours, if uterine content thickness was more than 15 mm the uterus was evacuated by dilation and curettage.
RESULTS: Of 403 women, 349 (86.6%) aborted following the basic regime; 207 (51.4%) (group A) were primiparous while 196 (48.6%) (group B) had at least one prior pregnancy. Uterine curettage was performed in 17 patients (8.2%) in group A and in 37 (18.9%) in group B (P = 0.002). When patients with a history of a previous abortion were excluded from group B, 32 of 143 (22.4%) required curettage (P < 0.001). When patients without a history of previous cesarean section were excluded, 10 of 52 (19.2%) underwent curettage (P = 0.038).
CONCLUSIONS: Previous pregnancies negatively affect the success of medical termination of pregnancy, especially in women with a previous term pregnancy. This information is important when counseling women about the method of pregnancy termination.
Authors:
Marwan Odeh; Rene Tendler; Vladimir Sosnovsky; Mohamad Kais; Ella Ophir; Jacob Bornstein
Related Documents :
5575236 - Termination of pregnancy by the intrauterine insertion of utus paste.
12819986 - Mirtazapine (remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin...
3659576 - Bronchoalveolar lavage during third-trimester pregnancy in patients with status asthmat...
16913556 - Uterine perforation as a rare complication of attempted pregnancy termination with miso...
8841226 - Fetal startle response observed under ultrasonography: a good predictor of a reassuring...
22459826 - Effect of endocervical inflammation on days to conception in dairy cows.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Israel Medical Association journal : IMAJ     Volume:  12     ISSN:  1565-1088     ISO Abbreviation:  Isr. Med. Assoc. J.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-11-24     Completed Date:  2010-12-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100930740     Medline TA:  Isr Med Assoc J     Country:  Israel    
Other Details:
Languages:  eng     Pagination:  606-8     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Western Galilee Hospital, Nahariya, Israel. marwan20@bezeqint.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents
Abortion, Induced*
Adult
Cohort Studies
Female
Gravidity*
Humans
Israel
Mifepristone
Misoprostol
Parity*
Pregnancy
Retrospective Studies
Treatment Outcome
Chemical
Reg. No./Substance:
0/Abortifacient Agents; 59122-46-2/Misoprostol; 84371-65-3/Mifepristone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Validity of self-reported weight and height among 13-14 year old schoolchildren in Israel.
Next Document:  Achilles tendon rupture and our experience with the Achillon device.